McMaster University

McMaster University

Seminal Canadian Recommendations for Evidence-Based Examination of Neonates for Retinopathy of Prematurity (SCREEN-ROP) Study

SCREEN-ROP

Seminal Canadian Recommendations for Evidence-Based Examination of Neonates for Retinopathy of Prematurity (SCREEN-ROP) Study

Principal Investigator: Dr. Kourosh Sabri

Current Involvement: All 30 Level-3 Neonatal Intensive Care Units in Canada

Funded By: CIHR-Partnerships for Health Systems Improvement, Ministry of Health and Long-Term Care and the McMaster University Department of Surgery

Study Summary

Dr. Sabri recently presented on the SCREEN-ROP study at the Canadian Opthamological Society Annual Meeting in Toronto ON.

The primary objective of this study is to develop evidence-based recommendations for retinopathy of prematurity (ROP) screening that minimize the number of patients being screened as well as associated costs and morbidities while still capturing all nascent cases of ROP. This study is in partnership with the Canadian Neonatal Network™ and involves all 30 Level-3 Neonatal Intensive Care Units in Canada.

What is Retinopathy of Prematurity?

Retinopathy of prematurity (ROP) is a vascular disease of the retina that primarily affects premature infants. Abnormal retinal blood vessels due to prematurity can cause strain on the retina and even detachment resulting in severe visual impairment. Several risk factors for the development of severe ROP have been identified such as too much oxygen, low birth weight (BW) and low gestational age at birth (GA).  While ROP can be severe enough to require treatment, most cases resolve spontaneously.

What is the SCREEN-ROP Study?

The SCREEN-ROP Study is a CIHR –funded study that is being headed by McMaster University and involves 30 hospitals across Canada. The SCREEN-ROP Study is designed to develop new evidence-based screening guidelines for ROP that will reduce that number of patients screened while still capturing all patients with severe ROP requiring treatment. The ultimate goal of these new guidelines is to reduce the morbidity of ROP screening on the patient and parent as well as capture every single patient with ROP.

For more information on the SCREEN-ROP study,
please contact the Study Coordinator:

Sahira Husain, B.Sc
phone:905-521-2100 x. 73510
email: shusain@mcmaster.ca

Resources

 

For more information, please visit the
SCREEN-ROP website

SCREEN-ROP

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0